TABLE II.
Viral Factors that Alter Host Immune Functions and Subsequently Result in Increased Virus Survival
Host defense | Virus(es) | Viral factor | Activity | Fitnessa | References |
---|---|---|---|---|---|
Interleukins | Vaccinia/Cowpox | B15R | Binds to IL-1 & prevents normal function | Population | Spriggs et al. (1992), Alcami & Smith (1992) |
Cowpox | crmA | Prevents IL-1β maturation | Population | Ray et al. (1992) | |
EBV | BCRF-1 | Blocks IL-10 synthesis | Population | Moore et al. (1993) | |
Tanapox | 38 kDa | Binds 1L-2 and IL-5 | Population | Essani et al. (1994) | |
Interferons | Adenoviruses | VA RNA | Block IFN-induced autophosphorylation of DAI | Individual | Matthews & Shenk (1991) |
E1A | Block IFN transcriptional signaling | Individual | Ackrill et al (1991), Kalvakolanu et al (1991), Gutch & Reich (1991) | ||
EBV | EBER RNA | DAI function inhibition | Individual | Bhat & Thimmappaya (1983) | |
IL-10 homologue | Downregulates IFNγ synthesis | Individual | Moore et al. (1990) | ||
HIV-I | Tat | Decreases PKR expression | Individual | Roy et al. (1990) | |
Reoviruses | σ3 | Blocks activation of IFN-induced PKR | Individual | Imani & Jacobs (1988), Lloyd & Shatkin (1992) | |
HBV | Terminal protein | Blocks IFN transcriptional signaling | Population | Foster et al. (1991) | |
HSV-I | 2-5(A) analogues | Blocks activation of IFN-induced PKR | Individual | Katze (1992), Sen & Ransohoff (1993) | |
Myxoma | M-T7 | Binds to and neutralizes IFNγ | Population | Upton et al. (1992) | |
Influenza | Cellular P58 | Inhibits IFN-induced PKR via cell protein activation | Individual | Lee et al. (1990) | |
Vaccinia | E3L | Blocks activation of IFN induced PKR | Individual | Chang et al. (1992) | |
K3L | PKR decoy substrate | Individual | Davies et al. (1993) | ||
Complement | Vaccinia | C21L | Blocks alternative & classical complement activation | Population | Kotwal et al (1990), Isaacs et al (1992) |
components | Herpesvirus saimiri | ORF 4 | Blocks alternative & classical complement activation | Population | Albrecht & Fleckenstein (1992) |
ORF 15 | Inhibits membrane attack complex | Individual | Albrecht et al. (1992) | ||
Herpes simplex | Glycoprotein C | Blocks alternative & classical complement activation | Individual | Fries et al. (1986), McNeamey et al. (1987), Harris et al. (1990) | |
EBV | Whole virion | Inhibits alternative pathway function | Population | Mold et al. (1988) | |
TNF | Shope fibroma virus | T2 | Binds to TNF and inhibits function | Population | Smith et al. (1991), Upton et at. (1991), Pickup et at. (1993) |
Adenoviruses | E1B | Increase resistance of cells to TNF- induced lysis & apoptosis | Individual | Gooding et al. (1991), White et al. (1992) | |
E3 | Increase resistance of cells to TNF-induced lysis | Individual | Gooding et al. (1988) | ||
MHC-I | Adenoviruses | E3 (19kDa gp) | Sequesters MHC proteins within ER | Individual | Anderson et al. (1987), Pääbo et al. (1987), Rawle et al. (1989) |
Adenovirus 12 | E1A | Inhibits MHC-I transcription | Individual | Schrier et al. (1983), Ackrill & Blair (1988). Ge et al. (1992) | |
MCMV | Early protein(s) | Prevents peptide-bound MHC-I transport to surface | Individual | del Val et al. (1992) | |
Other | HCMV | US28 | Binds to and sequesters C—C chemokines | Population | Neote (1993) |
Myxoma | T2 | Binds to & sequesters serpins | Population | Lomas et al. (1993), Upton et al. (1990), Macen et al. (1993) | |
Poxviruses | EGF-like proteins | Stimulates regional cell growth to enhance progeny virus replication | Population | Brown et al. (1985), Chang et al. (1987) | |
MMTV | LTR ORF | Stimulates T- & B-cell proliferation to enhance progeny virus replication | Population | Choi et al. (1991), Korman et al. (1992), Held et al. (1993), Golovkina et al. (1992) | |
EBV | LMP-1, LMP-2 | B-cell activation & latent-to-lytic infection switch | Population | Miller et al. (1993), Burkhardt et al. (1992) |
“Fitness” refers to whether the factor contributes to viral population or individual viral fitness.